Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
LyondellBasell Industries
LYB
$20.2B
| $19.9M | 0.05% |
+203,600
| New | +$19.4M |
|
477
IAMGOLD
IAG
$10.1B
| $19.9M | 0.05% |
4,819,896
+4,087,299
| +558% | +$14.5M |
|
|
CBL
478
DELISTED
CBL& Associates Properties, Inc.
CBL
| $19.9M | 0.05% |
1,045,017
-1,259,800
| -55% | -$23.3M |
|
479
Caleres
CAL
$461M
| $19.8M | 0.05% |
692,850
-245,707
| -26% | -$6.43M |
|
|
FISV
480
Fiserv Inc
FISV
$29.5B
| $19.8M | 0.05% |
+656,808
| New | +$19.5M |
|
|
CIE
481
DELISTED
Cobalt International Energy, Inc
CIE
| $19.8M | 0.05% |
71,947
+38,830
| +117% | +$10.6M |
|
482
Open Text
OTEX
$6.02B
| $19.7M | 0.05% |
820,416
+372,600
| +83% | +$8.83M |
|
483
Kulicke & Soffa
KLIC
$5.01B
| $19.5M | 0.05% |
1,369,500
-791,728
| -37% | -$10.9M |
|
484
Kinross Gold
KGC
$31.9B
| $19.5M | 0.05% |
4,709,892
+3,422,701
| +266% | +$13.9M |
|
|
CBEY
485
DELISTED
CBEYOND INC COM STK
CBEY
| $19.5M | 0.05% |
1,956,704
+613,411
| +46% | +$5.72M |
|
486
EXL Service
EXLS
$5.36B
| $19.4M | 0.05% |
3,302,000
+70,000
| +2% | +$405K |
|
487
Evertec
EVTC
$1.91B
| $19.4M | 0.05% |
+802,000
| New | +$19.1M |
|
488
Fomento Económico Mexicano
FMX
$39.7B
| $19.4M | 0.05% |
207,200
-35,700
| -15% | -$3.39M |
|
489
MannKind Corp
MNKD
$1.2B
| $19.4M | 0.05% |
+353,960
| New | +$14.2M |
|
|
JNPR
490
DELISTED
Juniper Networks
JNPR
| $19.4M | 0.05% |
790,191
-2,703,600
| -77% | -$67.2M |
|
|
IM
491
DELISTED
Ingram Micro
IM
| $19.4M | 0.05% |
663,200
-792,044
| -54% | -$22.2M |
|
492
EOG Resources
EOG
$74.2B
| $19.4M | 0.05% |
165,600
-921,400
| -85% | -$96.9M |
|
|
STMP
493
DELISTED
Stamps.com, Inc.
STMP
| $19.3M | 0.05% |
573,751
-128,760
| -18% | -$4.19M |
|
494
Rogers Communications
RCI
$19.7B
| $19.2M | 0.04% |
478,100
-75,800
| -14% | -$3.07M |
|
|
FRC
495
DELISTED
First Republic Bank
FRC
| $19.2M | 0.04% |
349,500
-119,300
| -25% | -$6.27M |
|
|
NTRI
496
DELISTED
NutriSystem, Inc.
NTRI
| $19.2M | 0.04% |
1,121,600
-452,000
| -29% | -$7.21M |
|
|
AXE
497
DELISTED
Anixter International Inc
AXE
| $19.2M | 0.04% |
191,500
+129,900
| +211% | +$12.8M |
|
498
Cisco
CSCO
$447B
| $19.2M | 0.04% |
+771,005
| New | +$18.4M |
|
|
MNK
499
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $19.1M | 0.04% |
238,900
-15,200
| -6% | -$1.1M |
|
500
Madison Square Garden
MSGS
$9.94B
| $19.1M | 0.04% |
429,152
-265,679
| -38% | -$10.4M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.